Logo image of FHI

FEDERATED HERMES INC (FHI) Stock Fundamental Analysis

NYSE:FHI - New York Stock Exchange, Inc. - US3142111034 - Common Stock - Currency: USD

42.13  -0.7 (-1.63%)

After market: 42.13 0 (0%)

Fundamental Rating

7

Overall FHI gets a fundamental rating of 7 out of 10. We evaluated FHI against 232 industry peers in the Capital Markets industry. FHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. FHI is valued quite cheap, while showing a decent growth score. This is a good combination! This makes FHI very considerable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

FHI had positive earnings in the past year.
FHI had a positive operating cash flow in the past year.
Each year in the past 5 years FHI has been profitable.
Each year in the past 5 years FHI had a positive operating cash flow.
FHI Yearly Net Income VS EBIT VS OCF VS FCFFHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of FHI (17.65%) is better than 97.41% of its industry peers.
The Return On Equity of FHI (32.83%) is better than 96.12% of its industry peers.
FHI has a Return On Invested Capital of 22.88%. This is amongst the best in the industry. FHI outperforms 98.28% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FHI is significantly above the industry average of 7.88%.
The last Return On Invested Capital (22.88%) for FHI is above the 3 year average (16.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.65%
ROE 32.83%
ROIC 22.88%
ROA(3y)12.38%
ROA(5y)13.04%
ROE(3y)23.49%
ROE(5y)24.27%
ROIC(3y)16.23%
ROIC(5y)16.25%
FHI Yearly ROA, ROE, ROICFHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a Profit Margin value of 17.15%, FHI perfoms like the industry average, outperforming 54.31% of the companies in the same industry.
FHI's Profit Margin has declined in the last couple of years.
FHI has a Operating Margin (27.37%) which is in line with its industry peers.
FHI's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 95.30%, FHI belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
In the last couple of years the Gross Margin of FHI has remained more or less at the same level.
Industry RankSector Rank
OM 27.37%
PM (TTM) 17.15%
GM 95.3%
OM growth 3Y-3.42%
OM growth 5Y0.08%
PM growth 3Y-7.67%
PM growth 5Y-4.49%
GM growth 3Y-0.05%
GM growth 5Y-0.31%
FHI Yearly Profit, Operating, Gross MarginsFHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, FHI has less shares outstanding
Compared to 5 years ago, FHI has less shares outstanding
FHI has a worse debt/assets ratio than last year.
FHI Yearly Shares OutstandingFHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FHI Yearly Total Debt VS Total AssetsFHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 5.31 indicates that FHI is not in any danger for bankruptcy at the moment.
FHI has a better Altman-Z score (5.31) than 85.78% of its industry peers.
The Debt to FCF ratio of FHI is 1.02, which is an excellent value as it means it would take FHI, only 1.02 years of fcf income to pay off all of its debts.
FHI has a better Debt to FCF ratio (1.02) than 87.50% of its industry peers.
A Debt/Equity ratio of 0.32 indicates that FHI is not too dependend on debt financing.
FHI has a better Debt to Equity ratio (0.32) than 73.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.02
Altman-Z 5.31
ROIC/WACCN/A
WACCN/A
FHI Yearly LT Debt VS Equity VS FCFFHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

FHI has a Current Ratio of 3.04. This indicates that FHI is financially healthy and has no problem in meeting its short term obligations.
FHI has a Current ratio of 3.04. This is amongst the best in the industry. FHI outperforms 80.17% of its industry peers.
A Quick Ratio of 3.04 indicates that FHI has no problem at all paying its short term obligations.
FHI has a Quick ratio of 3.04. This is amongst the best in the industry. FHI outperforms 80.17% of its industry peers.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 3.04
FHI Yearly Current Assets VS Current LiabilitesFHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.85% over the past year.
The Earnings Per Share has been growing slightly by 3.47% on average over the past years.
FHI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.68%.
FHI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.26% yearly.
EPS 1Y (TTM)0.85%
EPS 3Y3.71%
EPS 5Y3.47%
EPS Q2Q%40.45%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y7.92%
Revenue growth 5Y4.26%
Sales Q2Q%6.85%

3.2 Future

The Earnings Per Share is expected to grow by 12.89% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.46% on average over the next years.
EPS Next Y34.46%
EPS Next 2Y16.5%
EPS Next 3Y12.02%
EPS Next 5Y12.89%
Revenue Next Year4.87%
Revenue Next 2Y4.17%
Revenue Next 3Y4.13%
Revenue Next 5Y2.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FHI Yearly Revenue VS EstimatesFHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
FHI Yearly EPS VS EstimatesFHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.87, the valuation of FHI can be described as reasonable.
FHI's Price/Earnings ratio is a bit cheaper when compared to the industry. FHI is cheaper than 64.66% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.31. FHI is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.73, the valuation of FHI can be described as very reasonable.
FHI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. FHI is cheaper than 71.55% of the companies in the same industry.
FHI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 11.87
Fwd PE 9.73
FHI Price Earnings VS Forward Price EarningsFHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FHI indicates a rather cheap valuation: FHI is cheaper than 93.53% of the companies listed in the same industry.
FHI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. FHI is cheaper than 76.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.73
EV/EBITDA 5.09
FHI Per share dataFHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

FHI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FHI has an outstanding profitability rating, which may justify a higher PE ratio.
FHI's earnings are expected to grow with 12.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.34
PEG (5Y)3.42
EPS Next 2Y16.5%
EPS Next 3Y12.02%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.18%, FHI has a reasonable but not impressive dividend return.
FHI's Dividend Yield is comparable with the industry average which is at 7.98.
FHI's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 3.18%

5.2 History

On average, the dividend of FHI grows each year by 15.47%, which is quite nice.
FHI has paid a dividend for at least 10 years, which is a reliable track record.
FHI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)15.47%
Div Incr Years2
Div Non Decr Years3
FHI Yearly Dividends per shareFHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

FHI pays out 52.75% of its income as dividend. This is a bit on the high side, but may be sustainable.
FHI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP52.75%
EPS Next 2Y16.5%
EPS Next 3Y12.02%
FHI Yearly Income VS Free CF VS DividendFHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
FHI Dividend Payout.FHI Dividend Payout, showing the Payout Ratio.FHI Dividend Payout.PayoutRetained Earnings

FEDERATED HERMES INC

NYSE:FHI (6/13/2025, 8:04:00 PM)

After market: 42.13 0 (0%)

42.13

-0.7 (-1.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners81.98%
Inst Owner ChangeN/A
Ins Owners3.99%
Ins Owner Change3.43%
Market Cap3.33B
Analysts52
Price Target43.01 (2.09%)
Short Float %3.6%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield 3.18%
Yearly Dividend2.22
Dividend Growth(5Y)15.47%
DP52.75%
Div Incr Years2
Div Non Decr Years3
Ex-Date05-08 2025-05-08 (0.34)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.36%
Min EPS beat(2)5.9%
Max EPS beat(2)34.82%
EPS beat(4)3
Avg EPS beat(4)-5.65%
Min EPS beat(4)-77.66%
Max EPS beat(4)34.82%
EPS beat(8)6
Avg EPS beat(8)-1%
EPS beat(12)9
Avg EPS beat(12)0.99%
EPS beat(16)11
Avg EPS beat(16)0.21%
Revenue beat(2)1
Avg Revenue beat(2)-0.19%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)0.11%
Revenue beat(4)1
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)0.11%
Revenue beat(8)2
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)7.54%
Revenue beat(16)6
Avg Revenue beat(16)4.82%
PT rev (1m)3.27%
PT rev (3m)3.27%
EPS NQ rev (1m)1.84%
EPS NQ rev (3m)-0.79%
EPS NY rev (1m)0%
EPS NY rev (3m)5.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.53%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-1.66%
Valuation
Industry RankSector Rank
PE 11.87
Fwd PE 9.73
P/S 1.62
P/FCF 9.73
P/OCF 9.61
P/B 3.1
P/tB N/A
EV/EBITDA 5.09
EPS(TTM)3.55
EY8.43%
EPS(NY)4.33
Fwd EY10.28%
FCF(TTM)4.33
FCFY10.27%
OCF(TTM)4.38
OCFY10.41%
SpS26.04
BVpS13.6
TBVpS-0.79
PEG (NY)0.34
PEG (5Y)3.42
Profitability
Industry RankSector Rank
ROA 17.65%
ROE 32.83%
ROCE 31.69%
ROIC 22.88%
ROICexc 32.91%
ROICexgc 413.75%
OM 27.37%
PM (TTM) 17.15%
GM 95.3%
FCFM 16.62%
ROA(3y)12.38%
ROA(5y)13.04%
ROE(3y)23.49%
ROE(5y)24.27%
ROIC(3y)16.23%
ROIC(5y)16.25%
ROICexc(3y)23.98%
ROICexc(5y)23%
ROICexgc(3y)1021.49%
ROICexgc(5y)802.2%
ROCE(3y)22.48%
ROCE(5y)22.5%
ROICexcg growth 3Y38.23%
ROICexcg growth 5Y38.01%
ROICexc growth 3Y9.02%
ROICexc growth 5Y7%
OM growth 3Y-3.42%
OM growth 5Y0.08%
PM growth 3Y-7.67%
PM growth 5Y-4.49%
GM growth 3Y-0.05%
GM growth 5Y-0.31%
F-Score5
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.02
Debt/EBITDA 0.59
Cap/Depr 19.92%
Cap/Sales 0.21%
Interest Coverage 250
Cash Conversion 59.19%
Profit Quality 96.9%
Current Ratio 3.04
Quick Ratio 3.04
Altman-Z 5.31
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)21%
Cap/Depr(5y)28.99%
Cap/Sales(3y)0.35%
Cap/Sales(5y)0.55%
Profit Quality(3y)126.81%
Profit Quality(5y)111.36%
High Growth Momentum
Growth
EPS 1Y (TTM)0.85%
EPS 3Y3.71%
EPS 5Y3.47%
EPS Q2Q%40.45%
EPS Next Y34.46%
EPS Next 2Y16.5%
EPS Next 3Y12.02%
EPS Next 5Y12.89%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y7.92%
Revenue growth 5Y4.26%
Sales Q2Q%6.85%
Revenue Next Year4.87%
Revenue Next 2Y4.17%
Revenue Next 3Y4.13%
Revenue Next 5Y2.46%
EBIT growth 1Y12.71%
EBIT growth 3Y4.23%
EBIT growth 5Y4.35%
EBIT Next Year62.14%
EBIT Next 3Y11.97%
EBIT Next 5Y8.11%
FCF growth 1Y-0.86%
FCF growth 3Y28.89%
FCF growth 5Y1.38%
OCF growth 1Y-0.51%
OCF growth 3Y26.7%
OCF growth 5Y0.69%